Furthermore, Srxn1 overexpression significantly reduced LVESD, LVEDD, and increased LVEF, LVFS compared to sham mice, indicating that Srxn1 overexpression could ameliorate TAC‐induced cardiac dysfunction (Figure 3A–E). The gene discussed is SRXN1; the disease is persistent truncus arteriosus.